Journal of clinical oncology (JCO) |
National Trends in Nonoperative Management of Rectal Adenocarcinoma. |
juin. 16 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Randomized Comparison of Surveillance Intervals in Familial Colorectal Cancer |
nov. 15 |
4 ♥ |
Endoscopie/Imagerie, Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial. |
mai. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer |
nov. 15 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. |
juin. 16 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study. |
mar. 19 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome. |
mai. 19 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. |
mar. 19 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. |
fév. 19 |
3 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2. |
Jan. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110). |
Jan. 19 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. |
mar. 18 |
4 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Popstantot |
mai. 18 |
5 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database. |
mai. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis. |
mai. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. |
oct. 18 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Associations of Pre- and Postdiagnosis Diet Quality With Risk of Mortality Among Men and Women With Colorectal Cancer |
oct. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial. |
juil. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. |
mar. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial. |
sep. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of Hepatology |
Factors associated with spontaneous clearance of chronic hepatitis C virus infection |
aoû. 16 |
4 ♥ |
Foie |
Journal of Hepatology |
Global genotype distribution of hepatitis C viral infection among people who inject drugs. |
déc. 16 |
2 ♥ |
Foie |
Journal of Hepatology |
Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents |
sep. 17 |
4 ♥ |
Foie |
Journal of Hepatology |
Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment |
oct. 15 |
3 ♥ |
Foie, Hépatites virales |